EANM consensus document on the use of [ 18 F]FDG PET/CT in fever and inflammation of unknown origin.
Soren HessEdel Noriega-ÁlvarezLucia LeccisottiGiorgio TregliaDomenico AlbanoAnne RoivainenAndor W J M GlaudemansOlivier GheysensPublished in: European journal of nuclear medicine and molecular imaging (2024)
F]FDG PET/CT has a definite role in the diagnostic pathway with an overall diagnostic yield or helpfulness in 50-60% of patients. A positive scan is often contributory by directly guiding treatment or subsequent diagnostic procedure. However, a negative scan may be equally important by excluding focal disease and predicting a favorable prognosis. Similar results are obtained in specific populations such as ICU-patients, children and HIV-patients.